GlassScriptPhysician profile
Ryan Aboulhosn
NPI 1467651919
$18,016.70
in general payments reported to CMS, 2019-2025
8 companies · $77.65 in 2025
The $77.65 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $289 · 2021: $556 · 2022: $1,312 · 2023: $12K · 2024: $4,152 · 2025: $77.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,325 · Food and Beverage: $3,137 · Travel and Lodging: $2,711 · Consulting Fee: $1,500 · Entertainment: $61.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,325.00 |
| Food and Beverage | $3,136.51 |
| Travel and Lodging | $2,711.39 |
| Consulting Fee | $1,500.00 |
| Entertainment | $61.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $16,513.01 | 2022-2024 | Infuse, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $810.91 | 2020-2021 | |
| Alcon Vision LLC | $331.34 | 2019-2025 | Wavelight Refractive Suite, Wavelight Ex500 Excimer Laser |
| Glaukos Corporation | $121.55 | 2024 | Idose |
| Ocular Therapeutix, INC. | $117.65 | 2023 | Dextenza |
| Optos, INC. | $61.14 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $33.73 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $27.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Aboulhosn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.